Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 4 regulatory subunit 3B (PPP4R3B) is a regulatory subunit of the serine/threonine-protein phosphatase 4 (PP4) complex[5][4], which participates in the regulation of cellular protein dephosphorylation processes. PPP4R3B forms heterotrimeric complexes with PP4C (the catalytic subunit) and other regulatory subunits (such as PP4R2)[3]. It is involved in the regulation of double-strand break repair and DNA damage response—critical for maintaining genomic stability—by influencing the activity and substrate specificity of the PP4 phosphatase complex[4][1][3]. PPP4R3B localizes to the nucleus, centrosome, and chromatin[4][5]. While gene-disease association data link PPP4R3B to several inherited conditions (such as sarcosinemia and intracranial abscess), it is not currently known as a direct drug target nor are there any drugs with established mechanisms acting upon it[4]. PPP4R3B, as part of the PP4 complex, plays a crucial biological function in response to DNA damage, and its dysregulation can have significant effects on cell cycle, DNA repair, and possibly tumorigenesis[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 4 regulatory subunit 3B (PPP4R3B).